Back
Aptevo Therapeutics Stock Price Chart
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
31
APVO
Aptevo Therapeutics
Last Price:
0.21
Seasonality Move:
-25.41%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APVO is experiencing selling pressure, which indicates risk of future bearish movement.
Aptevo Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.26 | Sell |
| 20-day SMA: | 0.27 | Sell |
| 50-day SMA: | 0.23 | Sell |
| 200-day SMA: | 1.64 | Sell |
| 8-day EMA: | 0.25 | Sell |
| 20-day EMA: | 0.25 | Sell |
| 50-day EMA: | 0.27 | Sell |
| 200-day EMA: | 5.75 | Sell |
Aptevo Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 43.7 | Sell |
| Chaikin Money Flow: | -700208 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.2 - 0.3) | Sell |
| Bollinger Bands (100): | (0.21 - 0.41) | Sell |
Aptevo Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aptevo Therapeutics Stock
Is Aptevo Therapeutics Stock a Buy?
- Aptevo Therapeutics share price is 0.21 while APVO 8-day simple moving average is 0.26, which is a Sell signal.
- The stock price of APVO is 0.21 while Aptevo Therapeutics 20-day SMA is 0.27, which makes it a Sell.
- Aptevo Therapeutics 50-day simple moving average is 0.23 while APVO share price is 0.21, making it a Sell technically.
- APVO stock price is 0.21 and Aptevo Therapeutics 200-day simple moving average is 1.64, creating a Sell signal.
APVO Technical Analysis vs Fundamental Analysis
Sell
31
Aptevo Therapeutics (APVO)
is a Sell
Is Aptevo Therapeutics a Buy or a Sell?
-
Aptevo Therapeutics stock is rated a Sell
The current Aptevo Therapeutics [APVO] share price is $0.21. The Score for APVO is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Aptevo Therapeutics Stock Info
Market Cap:
3.91M
Price in USD:
0.21
Share Volume:
750.58K
Aptevo Therapeutics 52-Week Range
52-Week High:
10.80
52-Week Low:
0.14
Sell
31
Aptevo Therapeutics (APVO)
is a Sell
Aptevo Therapeutics Share Price Forecast
-
What is the Aptevo Therapeutics stock price today?
The Aptevo Therapeutics stock price is 0.21 USD today. -
Will APVO stock go up or go down?
Aptevo Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aptevo Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aptevo Therapeutics is overvalued.
Is Aptevo Therapeutics Stock a Buy?
- Aptevo Therapeutics share price is 0.21 while APVO 8-day exponential moving average is 0.25, which is a Sell signal.
- The stock price of APVO is 0.21 while Aptevo Therapeutics 20-day EMA is 0.25, which makes it a Sell.
- Aptevo Therapeutics 50-day exponential moving average is 0.27 while APVO share price is 0.21, making it a Sell technically.
- APVO stock price is 0.21 and Aptevo Therapeutics 200-day simple moving average is 5.75, creating a Sell signal.
Fundamental Analysis of Aptevo Therapeutics
Is Aptevo Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $95.13 per share, and an increase next year of $1.74 per share.
Technical Analysis of Aptevo Therapeutics
Should I short Aptevo Therapeutics stock?
- APVO Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Aptevo Therapeutics is a Buy
- Aptevo Therapeutics Relative Strength Index (RSI) is 43.7, which suggest Aptevo Therapeutics is oversold
- The Bollinger Bands (25) for Aptevo Therapeutics is (0.2 - 0.3), which suggest Aptevo Therapeutics is a Sell
- The Bollinger Bands (100) for Aptevo Therapeutics is (0.21 - 0.41), which suggest Aptevo Therapeutics is a Sell
* Aptevo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.